本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Autolus Therapeutics PLC

1.43
+0.08005.93%
盤後1.490.0600+4.20%18:20 EDT
成交量:116.66萬
成交額:166.57萬
市值:3.81億
市盈率:-1.65
高:1.49
開:1.34
低:1.33
收:1.35
資料載入中...

公司資料

公司名字:
Autolus Therapeutics PLC
交易所:
NASDAQ
成立時間:
2014
員工人數:
649
公司地址:
The Mediaworks,191 Wood Lane,White City,London,Greater London,United Kingdom
郵編:
W12 7FP
傳真:
- -
簡介:
Autolus Therapeutics plc於2018年2月2日在英格蘭和威爾士註冊成立。該公司是一家生物製藥公司,開發用於治療癌症和自身免疫性疾病的下一代程序性T細胞療法。使用該公司廣泛的專有和模塊化T細胞編程技術套件,該公司正在設計精確靶向、受控和高活性的T細胞療法,這些療法旨在更好地識別目標細胞、打破其防禦機制並攻擊和消除這些細胞。

董事

名稱
職位
Christian Itin
Chief Executive Officer and Chairman of the Board
Cynthia Butitta
Director
Jay T Backstrom
Director
John Berriman
Director
Joseph Anderson
Director
Kapil Dhingra
Director
Linda Bain
Director
Martin Murphy
Director

股東

名稱
職位
Christian Itin
Chief Executive Officer and Chairman of the Board
Christopher Vann
Senior Vice President, Chief Operating Officer
Andrew Oakley
Senior Vice President, Chief Financial Officer
David Brochu
Senior Vice President, Chief Technical Officer
Martin Pule
Senior Vice President, Founder, Chief Scientific Officer
Matthias Alder
Senior Vice President, Chief Business Officer and Secretary
Muhammad Al Hajj
Senior Vice President, Translational Sciences